Validation of transcutaneous bilirubinometer with Kramer's scale in term babies with neonatal jaundice
DOI:
https://doi.org/10.18203/2349-3291.ijcp20252597Keywords:
Neonatal jaundice, Kramer’s scale, Transcutaneous bilirubinometry, Bilirubin screening, Term neonatesAbstract
Background: Neonatal jaundice affects a significant proportion of newborns globally and, if unrecognized or inadequately managed, may lead to severe neurological complications. In low-resource settings, clinical assessment using Kramer’s scale is often the initial approach, though its subjective nature and limited accuracy warrant further evaluation. Transcutaneous bilirubinometry (TcB) offers a non-invasive, objective alternative for estimating bilirubin levels.
Methods: Across-sectional observational study was conducted involving 98 term neonates aged over 24 hours with clinical jaundice. Kramer’s zones were recorded and simultaneously TcB measurements were obtained using a handheld bilirubinometer. Data were analyzed using descriptive statistics, Pearson correlation, and one-way ANOVA
Results: The majority of neonates were classified under Kramer’s zones 2 (35.7%) and 3 (32.7%). Mean TcB levels increased progressively from zone 1 (4.06 mg/dl) to zone 5 (17.65 mg/dl), with the difference being statistically significant (p=0.01). A strong positive correlation was observed between Kramer’s zone and TcB (r=0.894, p<0.01), indicating a reliable association between clinical grading and bilirubin levels.
Conclusions: Kramer’s scale correlates strongly with TcB values and can be used as a reliable initial screening tool in term neonates. However, in neonates with higher Kramer’s zones, confirmatory testing using TcB or Total serum bilirubin (TSB) is recommended.
Metrics
References
Varughese PM. Kramer’s scale or transcutaneous bilirubinometry: the ideal choice of a pediatrician? can we trust our eyes? Int J Contemp Pediatr. 2019;6:1794-801. DOI: https://doi.org/10.18203/2349-3291.ijcp20193702
Esmaelzadeh-Saeieh S, Asgaripoor M, Kabir K, Motlagh AJ. Relationship among Bilirubin Levels Measured Using Three Methods of Transcutaneous, Serum, and Kramer’s Scale in Term Neonates. Iranian J Neonatol. 2022;13(2):32-8.
N, Joshi A, Poudyal P, Magar SR, Tui RL. Diagnostic Validity of Kramer’s Scale as Compared to Total Serum Bilirubin Neonates with Hyperbilirubinemia. Annapurna J Health Sci. 2022;2(2):66-9.
Mumtaz S, Shafiq MF, Khan KA, Hussain M, Rahman A, Shafiq S. Diagnostic Accuracy of Kramer Visual Assessment of Jaundice in Term Neonates Taking Total Serum Bilirubin Levels as the Gold Standard. Pak Armed Forces Med J. 2022;72(6):1953. DOI: https://doi.org/10.51253/pafmj.v72i6.6252
Gupta BK, Chaudhary N, Bhatia BD, Gupta B. Non invasive trans-cutaneous bilirubin as a screening test to identify the need for serum bilirubin assessment in healthy term neonates. J Universal College Med Sci. 2013;1(4):17-21. DOI: https://doi.org/10.3126/jucms.v1i4.9567
Ercan Ş, Özgün G. The accuracy of transcutaneous bilirubinometer measurements to identify the hyperbilirubinemia in outpatient newborn population. Clin Biochem. 2018;55:69-74. DOI: https://doi.org/10.1016/j.clinbiochem.2018.03.018
Kurnianto A, Bermawi H, Darmawanti A, Bahar E. Transcutaneous billirubinometry to estimate total serum bilirubin in neonatal jaundice. Paediat Indones. 2017;57(1):8-11. DOI: https://doi.org/10.14238/pi57.1.2017.8-11
Lim XJ, Ambigapathy S, Leong EL, Marmuji LZ, Phan AP, Hamdan FA, et al. Comparing Kramer’s rule with transcutaneous bilirubin vs. Kramer’s rule only in reducing total serum bilirubin sampling among neonates with jaundice. BMC Pediat. 2025;25(1):1-8. DOI: https://doi.org/10.1186/s12887-025-05423-z
Szabo P, Wolf M, Bucher HU, Haensse D, Fauchere JC, Arlettaz R. Assessment of jaundice in preterm neonates: comparison between clinical assessment, two transcutaneous bilirubinometers and serum bilirubin values. Acta Paediat. 2004;93(11):1491-5. DOI: https://doi.org/10.1111/j.1651-2227.2004.tb02635.x
Deore PP, Darwade AB, Pagare SD. Assessment of Cord Bilirubin, Total Serum Bilirubin and Transcutaneous Bilirubin for Predicting and Managing Neonatal Jaundice. Res J Med Sci. 2023;17:104-10.
Kamphuis AS, Bekhof J. Cephalocaudal progression of neonatal jaundice assessed by transcutaneous bilirubin measurements. Early Human Develop. 2021;160:105418. DOI: https://doi.org/10.1016/j.earlhumdev.2021.105418
Bhat JA, Sheikh SA, Wani ZA, Ara R, Bhat SU. Reliability of transcutaneous bilirubin estimation during phototherapy in term infants: A hospital-based observational study. Sahel Med J. 2020;23(1):17-21. DOI: https://doi.org/10.4103/smj.smj_11_19
Ghimire S, Shrestha BM, Shrestha PN. Comparison of Visual Assessment of Neonatal Jaundice by Kramer's rule with total serum bilirubin levels in a Tertiary care hospital of Nepal. Med J Pokhara Academy Heal Sci. 2021;4(2):NA.
Chandranaik D, Zakir S, Kamath L, Kamath N, Rao SS. Correlation of transcutaneous and serum bilirubin levels in late preterm and term neonates at a tertiary care center in south India. F1000Research. 2025;14:403. DOI: https://doi.org/10.12688/f1000research.162608.1
Shariati MK, Taleghani NT, Izadi N, Miri A, Tafti RT, Gorji FA. Which is more accurate: transcutaneous bilirubin measurement on the forehead or sternum? Arch Iranian Med. 2022;25(8):552-6. DOI: https://doi.org/10.34172/aim.2022.88
Riskin A, Tamir A, Kugelman A, Hemo M, Bader D. Is visual assessment of jaundice reliable as a screening tool to detect significant neonatal hyperbilirubinemia? J Pediat. 2008;152(6):782-7. DOI: https://doi.org/10.1016/j.jpeds.2007.11.003
Downloads
Published
How to Cite
Issue
Section
